Advertisement
<< Back To Article
Bristol-Myers Squibb's HIV Maturation Inhibitor Shows Promise

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

3 Comments

DSTgar

Dropped from development at Phase IIb in October, 2016. This was probably going to be too expensive anyway.

November 1, 2016

David

Interesting study, however, the convoluted VL measure stated hides the actual results. In my opinion, the VL should be stated (as it is in other studies) in the actual units of measure used in the standardized viral load tests being used. The stated units of measure hardly helps validate anything significant without clarification which makes these results suspect at best.

October 28, 2015 Orlando

Michael Roland

Another drug to drag out the suffering and make even more money for the drug companies. Get to work on something that will make you look like decent human beings.Like a cure

October 28, 2015 Portland

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.